Clinical Research Directory
Browse clinical research sites, groups, and studies.
Efficacy Evaluation of ActiGraft in Secondary Closure of Abdominal Surgical Wound Dehiscence
Sponsor: RedDress Ltd.
Summary
This is a prospective, single arm study, consisting of 20 women with abdominal surgical wound dehiscence that requires secondary closure. The participants will receive a weekly application of ActiGraft for 4 weeks, or until complete healing of the wound (the earlier of the two). An historic matched-control group of 20 patients will be compared retrospectively
Official title: A Prospective Study Evaluating the Efficacy of ActiGraft in Secondary Closure of Abdominal Surgical Wound Dehiscence
Key Details
Gender
FEMALE
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
20
Start Date
2021-08-01
Completion Date
2026-08-01
Last Updated
2024-11-15
Healthy Volunteers
No
Conditions
Interventions
ActiGraft
Whole blood clot (WBC) gel
Locations (1)
Meir Medical Center
Kfar Saba, Israel